155 related articles for article (PubMed ID: 7986144)
21. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
23. Identification of submicroscopic lymph node metastases in patients with malignant melanoma.
Heller R; King B; Baekey P; Cruse W; Reintgen D
Semin Surg Oncol; 1993; 9(3):285-9. PubMed ID: 8516618
[TBL] [Abstract][Full Text] [Related]
24. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
[TBL] [Abstract][Full Text] [Related]
25. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay.
Palmieri G; Ascierto PA; Cossu A; Mozzillo N; Motti ML; Satriano SM; Botti G; Caracò C; Celentano E; Satriano RA; Lissia A; Tanda F; Pirastu M; Castello G;
J Clin Oncol; 2001 Mar; 19(5):1437-43. PubMed ID: 11230489
[TBL] [Abstract][Full Text] [Related]
26. Detection of submicroscopic lymph node metastases in patients with melanoma.
Heller R; Becker J; Wasselle J; Baekey P; Cruse W; Wells K; Cox C; King B; Reintgen DS
Arch Surg; 1991 Dec; 126(12):1455-9; discussion 1459-60. PubMed ID: 1726818
[TBL] [Abstract][Full Text] [Related]
27. Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.
Davids V; Kidson SH; Hanekom GS
Melanoma Res; 2003 Jun; 13(3):313-24. PubMed ID: 12777989
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
29. Detection of occult lymph node metastases in esophageal cancer by minimally invasive staging combined with molecular diagnostic techniques.
Kassis ES; Nguyen N; Shriver SP; Siegfried JM; Schauer PR; Luketich JD
JSLS; 1998; 2(4):331-6. PubMed ID: 10036123
[TBL] [Abstract][Full Text] [Related]
30. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
31. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance.
Gradilone A; Ribuffo D; Silvestri I; Cigna E; Gazzaniga P; Nofroni I; Zamolo G; Frati L; Scuderi N; Aglianò AM
Ann Surg Oncol; 2004 Nov; 11(11):983-7. PubMed ID: 15525827
[TBL] [Abstract][Full Text] [Related]
32. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
[TBL] [Abstract][Full Text] [Related]
33. Detection of occult melanoma cells in sentinel lymph nodes and blood.
Reintgen DS; Conrad AJ
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
[TBL] [Abstract][Full Text] [Related]
34. Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes.
Goydos JS; Patel KN; Shih WJ; Lu SE; Yudd AP; Kempf JS; Bancila E; Germino FJ
J Am Coll Surg; 2003 Feb; 196(2):196-204; discussion 204-5. PubMed ID: 12595045
[TBL] [Abstract][Full Text] [Related]
35. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
37. Radioguided surgery for the ultrastaging of the patient with melanoma.
Joseph E; Messina J; Glass FL; Cruse CW; Rapaport DP; Berman C; Reintgen DS
Cancer J Sci Am; 1997; 3(6):341-5. PubMed ID: 9403046
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma.
Li W; Stall A; Shivers SC; Lin J; Haddad F; Messina J; Glass LF; Lyman G; Reintgen DS
Ann Surg; 2000 Jun; 231(6):795-803. PubMed ID: 10816622
[TBL] [Abstract][Full Text] [Related]
39. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
40. Molecular staging for patients with malignant melanoma.
Shivers S; Jakub J; Pendas S; Reintgen D
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1665-74. PubMed ID: 18020932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
